PedAM
Pediatric Disease Annotations & Medicines
| Disease | prostate cancer |
| Symptom | C0029896|ent disease |
| Sentences | 7 |
| PubMedID- 23533810 | Among prostate cancer patients, those with early recurrent disease with psa relapse had a halting or slowing of psa progression, whereas trials in patients with late-stage disease yielded disappointing results. |
| PubMedID- 22549847 | A rising serum prostate-specific antigen (psa) level is often the first indicator of recurrent disease in patients with prostate cancer treated with radiation therapy (rt) or radical prostatectomy (rp). |
| PubMedID- 20643445 | Conclusions: positron emission tomography/computerized tomography detected increased 11ccholine uptake, suggesting recurrent disease in 11% of patients with prostate cancer, increasing prostate specific antigen after radical prostatectomy and no evidence of disease on conventional imaging. |
| PubMedID- 25687535 | The authors concluded that 68ga-psma-hbed-cc is a very sensitive and specific pet tracer for the detection of prostate cancer with residual/recurrent disease and its metastases. |
| PubMedID- 23626811 | Many prostate cancer patients diagnosed with indolent disease (gs 6) are eligible for inclusion in active surveillance programs. |
| PubMedID- 23759081 | Six patients died from intecurrent disease without evidence of prostate cancer. |
| PubMedID- 23324165 | In contrast, in the us population, 40-60% of prostate cancer patients present with clinically inapparent disease, mostly diagnosed as t1c upon trans-rectal ultrasound guided (trus) biopsy . |
Page: 1